Irinotecan-d10 hydrochloride(Synonyms: 伊立替康 d10 (盐酸盐))

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Irinotecan-d10 hydrochloride (Synonyms: 伊立替康 d10 (盐酸盐))

Irinotecan-d10 hydrochloride 是 Irinotecan 的氘代物。Irinotecan ((+)-Irinotecan) 是一种拓扑异构酶 I (topoisomerase I) 抑制剂,可用于结肠癌和直肠癌的研究。

Irinotecan-d10 hydrochloride(Synonyms: 伊立替康 d10 (盐酸盐))

Irinotecan-d10 hydrochloride Chemical Structure

CAS No. : 718612-62-5

规格 价格 是否有货
1 mg ¥8100 询问价格 & 货期
5 mg ¥24000 询问价格 & 货期
10 mg ¥39000 询问价格 & 货期

* Please select Quantity before adding items.

生物活性

Irinotecan-d10 ((+)-Irinotecan-d10) hydrochloride is the deuterium labeled Irinotecan. Irinotecan ((+)-Irinotecan) is a topoisomerase I inhibitor, preventing religation of the DNA strand by binding to topoisomerase I-DNA complex[1][2].

体外研究
(In Vitro)

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

633.20

Formula

C33H29D10ClN4O6

CAS 号

718612-62-5

中文名称

伊立替康 d10 (盐酸盐)

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

    [2]. Morales C, et al. Antitumoral effect of irinotecan (CPT-11) on an experimental model of malignant neuroectodermal tumor. J Neurooncol. 2002 Feb;56(3):219-26.

    [3]. Pavillard V, et al. Determinants of the cytotoxicity of irinotecan in two human colorectal tumor cell lines. Cancer Chemother Pharmacol. 2002 Apr;49(4):329-35. Epub 2002 Jan 30.

    [4]. Allegrini G, et al. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice. Cancer Chemother Pharmacol. 2004 Mar;53(3):261-6. Epub 2003 Dec 5.

    [5]. Dela Cruz FS, et al. A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma. Genome Med. 2016 Oct 31;8(1):116.

    [6]. Huang MY, et al. Chemotherapeutic agent CPT-11 eliminates peritoneal resident macrophages by inducing apoptosis. Apoptosis. 2016 Feb;21(2):130-42.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务